Integral Ad Science Holding Corp. (NASDAQ:IAS) Short Interest Update

Integral Ad Science Holding Corp. (NASDAQ:IAS) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 6,860,000 shares, a growth of 8.2% from the May 31st total of 6,340,000 shares. Approximately 9.6% of the shares of the company are short sold. Based on an average daily trading volume, of 1,900,000 shares, the days-to-cover ratio is presently 3.6 days.

Insider Buying and Selling

In other Integral Ad Science news, CAO Alexis Gil II sold 2,792 shares of the stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total transaction of $25,379.28. Following the completion of the transaction, the chief accounting officer now directly owns 145,550 shares of the company’s stock, valued at approximately $1,323,049.50. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, CAO Alexis Gil II sold 2,792 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total transaction of $25,379.28. Following the completion of the sale, the chief accounting officer now directly owns 145,550 shares of the company’s stock, valued at approximately $1,323,049.50. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Lisa Utzschneider sold 8,044 shares of the firm’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $9.97, for a total value of $80,198.68. Following the sale, the chief executive officer now directly owns 203,139 shares of the company’s stock, valued at $2,025,295.83. The disclosure for this sale can be found here. Insiders sold 59,875 shares of company stock valued at $598,224 in the last three months. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Integral Ad Science

Several large investors have recently made changes to their positions in the company. Charles Schwab Investment Management Inc. lifted its holdings in Integral Ad Science by 19.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 398,422 shares of the company’s stock valued at $4,737,000 after buying an additional 65,160 shares during the period. Qube Research & Technologies Ltd acquired a new position in Integral Ad Science in the third quarter valued at $5,548,000. Sherbrooke Park Advisers LLC acquired a new position in Integral Ad Science in the third quarter valued at $140,000. iA Global Asset Management Inc. lifted its holdings in Integral Ad Science by 16.9% in the third quarter. iA Global Asset Management Inc. now owns 211,540 shares of the company’s stock valued at $2,515,000 after buying an additional 30,600 shares during the period. Finally, American Trust lifted its holdings in Integral Ad Science by 10.8% in the third quarter. American Trust now owns 13,328 shares of the company’s stock valued at $158,000 after buying an additional 1,302 shares during the period. Institutional investors and hedge funds own 95.78% of the company’s stock.

Integral Ad Science Trading Down 0.9 %

Shares of NASDAQ:IAS opened at $9.68 on Thursday. The company’s 50-day moving average price is $9.55 and its two-hundred day moving average price is $11.67. The company has a debt-to-equity ratio of 0.13, a current ratio of 4.32 and a quick ratio of 4.32. Integral Ad Science has a one year low of $7.98 and a one year high of $20.88. The stock has a market capitalization of $1.55 billion, a PE ratio of 968.00, a price-to-earnings-growth ratio of 1.69 and a beta of 1.54.

Integral Ad Science (NASDAQ:IAS) last issued its earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01). Integral Ad Science had a net margin of 0.59% and a return on equity of 0.32%. The company had revenue of $114.50 million for the quarter, compared to analysts’ expectations of $112.12 million. During the same period in the prior year, the firm earned $0.02 EPS. Integral Ad Science’s quarterly revenue was up 7.9% compared to the same quarter last year. On average, equities analysts forecast that Integral Ad Science will post 0.22 EPS for the current fiscal year.

Analysts Set New Price Targets

IAS has been the topic of several analyst reports. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a research report on Tuesday, May 7th. Loop Capital started coverage on shares of Integral Ad Science in a research note on Tuesday, April 30th. They set a “buy” rating and a $15.00 price target for the company. Barclays cut their target price on shares of Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, April 15th. Morgan Stanley restated an “equal weight” rating and issued a $12.00 price objective (down previously from $18.00) on shares of Integral Ad Science in a research report on Tuesday, April 16th. Finally, Craig Hallum dropped their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, May 10th. Three analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $16.77.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.